SHANGHAI FUDAN H YC-,10 (F:FDY) — Market Cap & Net Worth
Market Cap & Net Worth: SHANGHAI FUDAN H YC-,10 (FDY)
SHANGHAI FUDAN H YC-,10 (F:FDY) has a market capitalization of $104.94 Million (€89.76 Million) as of August 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #18960 globally and #1758 in its home market, demonstrating a 4.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SHANGHAI FUDAN H YC-,10's stock price €0.26 by its total outstanding shares 340000000 (340.00 Million). See FDY capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
SHANGHAI FUDAN H YC-,10 Market Cap History: 2020 to 2026
SHANGHAI FUDAN H YC-,10's market capitalization history from 2020 to 2026. Data shows growth from $43.80 Million to $104.94 Million (16.18% CAGR).
SHANGHAI FUDAN H YC-,10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SHANGHAI FUDAN H YC-,10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.18x
SHANGHAI FUDAN H YC-,10's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $55.37 Million | $1.14 Billion | $213.30 Million | 0.05x | 0.26x |
| 2022 | $68.89 Million | $1.03 Billion | $138.00 Million | 0.07x | 0.50x |
| 2023 | $63.16 Million | $850.73 Million | $108.63 Million | 0.07x | 0.58x |
| 2024 | $117.66 Million | $709.40 Million | $39.73 Million | 0.17x | 2.96x |
| 2025 | $123.22 Million | $685.80 Million | -$157.44 Million | 0.18x | N/A |
Competitor Companies of FDY by Market Capitalization
Companies near SHANGHAI FUDAN H YC-,10 in the global market cap rankings as of August 4, 2026.
Key companies related to SHANGHAI FUDAN H YC-,10 by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
SHANGHAI FUDAN H YC-,10 Historical Marketcap From 2020 to 2026
Between 2020 and today, SHANGHAI FUDAN H YC-,10's market cap moved from $43.80 Million to $ 104.94 Million, with a yearly change of 16.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €104.94 Million | -14.84% |
| 2025 | €123.22 Million | +4.73% |
| 2024 | €117.66 Million | +86.28% |
| 2023 | €63.16 Million | -8.31% |
| 2022 | €68.89 Million | +24.41% |
| 2021 | €55.37 Million | +26.41% |
| 2020 | €43.80 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of SHANGHAI FUDAN H YC-,10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.94 Million USD |
| MoneyControl | $104.94 Million USD |
| MarketWatch | $104.94 Million USD |
| marketcap.company | $104.94 Million USD |
| Reuters | $104.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SHANGHAI FUDAN H YC-,10
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technol… Read more